2023 ACMT | Annual Scientific Meeting

2023 ACMT | Annual Scientific Meeting

Includes a Live In-Person Event on 03/31/2023 at 8:00 AM (PDT)

  • Register
    • Early bird pricing available!
    • Non-member - Tier I - $795
    • Non-member - Tier II - $500
    • Non-member - Tier III - $400
    • Non-member - Tier IV - $350
    • Member - Tier I - $650
    • Member - Tier II - $425
    • Member - Tier III - $350
    • Member - Tier IV - $300
    • Regular Price after 02/17/2023 12:59 AM
    • Non-member - Tier I - $995
    • Non-member - Tier II - $600
    • Non-member - Tier III - $500
    • Non-member - Tier IV - $450
    • Member - Tier I - $750
    • Member - Tier II - $525
    • Member - Tier III - $450
    • Member - Tier IV - $400

2023 ACMT Annual Scientific Meeting

March 31 - April 2, 2023
San Diego, Marriott La Jolla, San Diego, CA

The ACMT Annual Scientific Meeting (ASM) is an opportunity for specialists in the field to gather together to learn from the cutting-edge research of their peers. After a 2-year hiatus, ACMT is back for a fully in-person meeting in 2023, complete with all the networking and social opportunities that make our events so rich with engagement. The day preceding the annual meeting, ACMT will have it’s Pre-Symposium on “Self-Harm, Suicidality, and the Poisoned Patient: The Intersection of Toxicology and Mental Health” on March 30th. And the day before that, on March 29th, we are delighted to announce that our sister organization, the American Academy of Clinical Toxicology (AACT) will be joining us with their own half-day Pre-Symposium “DEI in Toxicology: What it Means for Patients and Learners.”

Important Dates:

  • November 15, 2022 - Abstract Submission DEADLINE
  • December 15, 2022 - Open Mic, Shark Tank and Case Panel Submission DEADLINE
  • February 16, 2023 - Early-Bird Registration DEADLINE

Continuing Education

This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 14.25 Interprofessional Continuing Education (IPCE) credit for learning and change. 

Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

Purchase CE Credits


Please write to ACMT at events@acmt.net.

Registration Rates

Click here to learn more about ACMT registration tiers.


Early-Bird Rate*

Early-bird rates expire at midnight on FEBRUARY 16, 2023. Fees increase to the Regular Rate after this date, no exceptions.

Cancellation Policy

Cancellation Policy: Cancellations received in writing on or prior to February 16, 2023 will be refunded subject to a $150 processing fee. No refunds will be given after February 16, 2023. Please send cancellation request to ACMT at events@acmt.net.

Preliminary Agenda

This agenda is subject to change. All times listed are in local, Pacific Time Zone.

Friday, March 31, 2023

7:45 - 8:00 AM - Welcome & Introductions

8:00 - 9:00 AM - Platform Session 1

9:00 - 9:45 AM
Donovan Lectureship: Gut-Brain Axis and Psychoneuroendocrinology: Translation to Addiction Medicine
Lorenzo Leggio, MD, PhD, Branch Chief, NIDA and NIAAA, Acting Clinical Director and Deputy Scientific Director, NIDA, National Institutes of Health, Baltimore, MD

9:45 - 10:30 AM
The PFAS Epidemic: Addressing The Challenge
Alan Woolf, MD, MPH, FAAP, FACMT, FAACT, Director, Environmental Medicine Program, Boston Children's Hospital; Professor of Pediatrics, Harvard Medical School, Cambridge, MA

10:30 - 11:30 AM - Poster Session 1
10:45 - 11:15 AM - Moderated Poster Forum 1

11:30 - 1:00 PM - Break / Committee Meetings

1:00 - 2:00 PM
X-Factor: Xylazine
Joshua DeBord, PhD, Analytical Chemist, Center for Forensic Science Research and Education, Willow Grove, PA
Michael Levine, MD, FACMT, Associate Professor, Director of Toxicology, Department of Emergency Medicine, University of California, Los Angeles, CA
Matthew S. Salzman, MD, Assistant Professor of Emergency Medicine, Cooper University Health Care, Camden, NJ

2:00 - 3:00 PM
Tricks of the Trade: Pain and Perioperative Management in Patients with Opioid Use Disorder
Katherine Katzung, MD, FASAM, Chair, Emergency Department; Director, Toxicology & Addiction Medicine Program, Abbott Northwestern Hospital, Minneapolis, MN
JoAn Laes, MD, FACMT, FASAM, Addiction Medicine Physician, Hennepin Healthcare, Minneapolis, MI
Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY

3:00 - 3:30 PM
Annual Review of Medical Toxicology - Highest Impact Publications from 2022-2023
Daniel J. McCabe, MD, Emergency Medicine Physician, University of Iowa Hospitals & Clinics, Iowa City, IA

3:30 - 5:00 PM - Break / Committee Meetings

5:00 - 6:30 PM
Annual ACMT Members Recognition & Awards Meeting

6:30 - 8:00 PM
30th Anniversary - President's Reception

Saturday, April 1, 2023

7:50 - 8:00 AM - Morning Announcements

8:00 - 9:00 AM - Platform Session 2

9:00 - 9:30 AM
MedTox and Modern Warfare: Radiation and Current Events
Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT, Professor of Department of Emergency Medicine Professor, Emory University, Atlanta, GA

9:30 - 10:15 AM - ACMT Career Achievement Award 

10:15 - 11:15 AM - Poster Session 2
10:30 - 11:00 AM - Moderated Poster Forum 2

11:15 - 12:15 PM - AACT Panel

12:15 - 2:15 PM - Break / Committee Meetings

2:15 - 3:45 PM - MedTox Case Panel: Case-Based Conundrums

3:45 - 5:15 PM - MedTox Shark Tank Research Forum

5:15 - 6:45 PM - Open Mic Competition

Sunday, April 2, 2023

7:50 - 8:00 AM - Morning Announcements

8:00 - 9:00 AM - Lightning Oral Session

9:00 - 10:00 AM - International Sessions featuring APAMT, EAPCCT & MENATOX

10:00 - 11:00 AM - Poster Session 3
10:15 - 10:45 AM - Moderated Poster Forum 3

11:00 - 11:25 AM - Pick 1 of 2

Professional Development Workshop 1
A Toxicologist Loose in the Med School, Opportunities for Undergraduate Medical Education

Professional Development Workshop 2
The 7 Words You Can't (shouldn't) Say in Toxicology Publications

11:35 - 12:00 PM - Pick 1 of 2

Professional Development Workshop 3
Can you Escape the Toxin? Developing your own Toxicology Escape Room for Adult Learners

Professional Development Workshop 4
Supplementing Toxicology Fellowship Training to Enhance the Practice of Addiction Medicine

12:00 - 12:30 PM 
A Brief History of Pharmaceutical Compounding and the Errors Associated with It
Christopher James Watson, MD, Emergency Medicine Attending Physician, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Boston, MA
James D. Whitledge, MD, Emergency Medicine Attending Physician, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Boston, MA

12:30 - 1:00 PM
Novel Treatments in the Pipeline for Envenomations
Nicklaus Brandehoff, MD, Assistant Clinical Professor, Toxicology Associates, Aurora, CO

1:00 - 1:30 PM
Making Social Media Nontoxic to Toxicologists
Joshua D. Trebach, MD, Clinical Instructor, Ronald O. Perelman Department of Emergency Medicine, NYU Langone Health, New York, NY
Ryan Marino, MD, Assistant Professor, University Hospitals Cleveland & Case Western Reserve University School of Medicine, Cleveland, OH

Alexis Cates, DO

Attending Physician, Emergency Medicine and Medical Toxicology

Ochsner Medical Center

Alexis Cates, DO trained in Emergency Medicine and Medical Toxicology at Einstein Medical Center in Philadelphia, PA.  She recently returned home to New Orleans, LA and is now working to develop a Medical Toxicology division at Ochsner Medical Center.  Professionally, she enjoys academics, perinatal toxicology, and health policy.  She is the mother of two active boys, and she and her husband enjoy road trips and adventures with the kids.

Joshua DeBord, PhD

Senior Scientist

The Center for Forensic Science Research and Education

Dr. Joshua (Josh) DeBord is a Senior Scientist at the CFSRE working in the areas of forensic toxicology and forensic chemistry. Dr. DeBord joined the CFSRE in early 2022 and performs R&D on challenging toxicological casework and profiles physical drug evidence on projects related to the CFSRE’s drug characterization initiatives, including CFSRE’s NPS Discovery program.

Dr. DeBord graduated with a B.S., M.S., and Ph.D., each in Chemistry, from Florida International University (FIU) in Miami, FL. Dr. DeBord’s doctoral research was conducted under the mentorship of Professor José Almirall on profiling and geographic provenance determination of heroin. Before joining CFSRE, Dr. DeBord was employed at the North Louisiana Crime Lab in Shreveport, LA, as a forensic chemist and toxicologist. Beginning there in 2018, Dr. DeBord and two colleagues started the toxicology section from only blood ethanol analysis to ISO/IEC 17025:2017 accreditation for qualitative determination and quantitative measurement of most drugs by March 2020. He also assisted with the development and implementation of the North Louisiana Crime Lab’s statistical sampling procedure to reduce backlog in the large-seizure drug casework. He continued to perform casework analysis and expert testimony before joining CFSRE in 2022.

Dr. DeBord is passionate about teaching, research, and mentorship. His research interests focus on applied research for increasing the capabilities of publicly funded forensic labs and improving the work experience for forensic professionals.


Addiction Staff Physician

Abbott Northwestern Hospital, Allina Health

JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Lorenzo Leggio, MD, PhD

Branch Chief & Acting Clinical Director


Dr. Lorenzo Leggio is a Senior Investigator in the NIH Intramural Research Program (IRP) with faculty appointments both at NIDA and NIAAA. He serves as Chief of the Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, a joint NIDA and NIAAA laboratory. He also serves as the NIDA Deputy Scientific Director, NIDA Acting Clinical Director, and Chief of the NIDA IRP Translational Addiction Medicine Branch. He also serves as a NIH Senior Attending Medical Staff and as senior medical advisor to the NIAAA Director. Dr. Leggio received his M.D. and Ph.D. from the Catholic University of Rome and ‘Agostino Gemelli’ hospital, where he also completed residency and received Board Certification in Internal Medicine. He was a visiting research associate, then postdoctoral research associate in Psychiatry and Human Behavior at Brown University, Providence, RI. In 2010, he joined the faculty of the Brown University Medical School as Assistant Professor at the Brown University Center for Alcohol and Addiction Studies, where he still holds an adjunct appointment as Professor in Behavioral and Social Sciences. He is also an Adjunct Professor of Addiction Medicine at Johns Hopkins University and Adjunct Professor of Neuroscience at Georgetown University. 

Dr. Leggio’s clinical research has been primarily focused on the treatment of alcohol and substance use disorders, with a special emphasis on the role of microbiome-gut-liver-brain and neuroendocrine pathways as well as GABAergic pathways; and on the medical consequences of alcohol use disorder, focusing on alcohol-associated liver disease. As a Principal Investigator at Brown University, Dr. Leggio received extramural research funding from NIAAA and NIDA, as well as from Brown University, the European Foundation for Alcohol Research, ABMRF/The Foundation for Alcohol Research, and the Brain and Behavior Research Foundation (NARSAD Young Investigator Award). At Brown University first, and at the NIH since 2012, Dr. Leggio, together with his team, colleagues and collaborators have pioneered and conducted work on medication development, on the role of the microbiome-gut-liver-brain axis and on the role of neuroendocrine pathways in addictive behaviors via human laboratory studies and clinical trials as well as via translational and reverse translational experimental medicine approaches. 

In 2022, Dr. Leggio was elected Fellow of the American College on Neuropsychopharmacology. Among other awards, Dr. Leggio received the 2008 Nordmann Award from the European Society for Biomedical Research on Alcoholism, the 2016 Early Career Investigator Award from the Research Society on Alcoholism, the 2018 Eva King Killam Award from the American College on Neuropsychopharmacology and the 2020 Jacob P. Waletzky Award from the Society for Neuroscience.

Dan McCabe, MD

Director of the Division of Medical Toxicology & Associate Medical Director

University of Iowa & Iowa Poison Control Center

Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Assistant Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Associate Medical Director for the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.

Mark Mycyk, MD

Chair of Research

Cook County Health

Mark Mycyk currently serves as Editor-in-Chief of Journal of Medical Toxicology and Chair of Research in the Department of Emergency Medicine at Cook County Health in Chicago.

Jeffrey Suchard, MD

Professor of Clinical Emergency Medicine & Associate Dean for Basic Science Education

University of California, Irvine

Jeffrey Suchard is an Emergency Physician and Medical Toxicologist at the University of California, Irvine.  After undergraduate studies in Biochemistry at UC Berkeley, he attended medical school at UCLA, EM residency at UConn, then completed medical toxicology fellowship in Phoenix, AZ.  Dr. Suchard has worked clinically at UC Irvine since 1999 and began his current involvement in medical student education in 2010.  He teaches Epidemiology & Biostatistics to the MS1 class (since 2010), is the course director for MS2 Medical Pharmacology (since 2011), and serves as Associate Dean for Basic Science Education (since 2014).

Joshua Trebach, MD

Emergency Medicine Physician & Medical Toxicologist

University of Iowa Hospitals and Clinics

Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.

James Whitledge, MD

Medical Toxicology Fellow

Boston Children's Hospital

James Whitledge, MD is a Medical Toxicology Fellow at Boston Children's Hospital in Boston, MA. He is also an Emergency Physician at Beth Israel Deaconess Medical Center Boston, MA. In his free time he also is the current Co-Chair of the AACT Herbs & Dietary Supplements Section.


Associate Chief Medical Education Officer

Boston Children's Hospital

Dr. Alan D. Woolf is a pediatrician and medical toxicologist. He is the Associate Chief Medical Education Officer at Boston Children’s Hospital and a Professor of Pediatrics at Harvard Medical School. He is Medical Director of the Pediatric Environmental Health Center at Boston Children’s Hospital, Director of the Pediatric Environmental Health Fellowship Training Program, and Principal Investigator of the Region 1 New England Pediatric Environmental Health Specialty Unit. He is currently a member of the Executive Committee of the American Academy of Pediatrics’ Council on Environmental Health & Climate Change and a member of the PFAS Subcommittee of the National PEHSU Program. Dr. Woolf has served as a consultant regarding PFAS water contamination to both the New Hampshire and Massachusetts Departments of Public Health since 2014. He co-authored one of the first papers to describe the PFAS water contamination event in Portsmouth NH and was a ‘Community Liaison’ giving input to the NASEM Report on PFAS published in 2022. He is currently a member of the New Hampshire State Advisory Committee on PFAS and cancer. 

Dr. Woolf is a past-president of both the American Academy of Clinical Toxicology and the American Association of Poison Control Centers. In 2018, Dr. Woolf received the Career Achievement Award from the AACT and, in 2019, he was named the Louis Roche Lecturer by the European Association of Poisons Centers and Clinical Toxicologists. He is the Editor of the recent book The History of Modern Clinical Toxicology published by Elsevier Publishers in 2021.

Matthew Zuckerman, MD

Associate Professor

University of Colorado School of Medicine

Dr. Matt Zuckerman is an medical toxicologist at the University of Colorado Anschutz Medical Campus and Rocky Mountain Poison & Drug Safety. He is the pharmacology content director for the CU School of Medicine curriculum.


We are no longer accepting abstracts for the 2023 ACMT Annual Scientific Meeting. The submission period is now closed and all abstracts that were submitted are currently under review. Decision notifications will be emailed to submission authors in mid-December.


If you have any questions, please contact ACMT at asmresearch@acmt.net.

MedTox Case Panel

The Education Committee invites Fellows-in-Training and ACMT Members to submit a case of a unique or interesting patient for presentation at the “MedTox Case Panel: Case-Based Conundrums" taking place during the 2023 ACMT Annual Scientific Meeting, March 31 - April 2, 2022 in San Diego, CA.

Three cases will be selected for presentation and discussion by a panel of Medical Toxicology specialists. All cases will be considered, but there is a specific interest in complex or controversial management issues encountered by the medical toxicologist.

The 2023 ACMT Annual Scientific Meeting will be fully in-person. Presenters will be expected to register for the meeting and present in-person on the main stage in San Diego. There will be no virtual option.

How to Apply:

Please submit a 500 word max. abstract of the case that includes:

  1. Initial Clinical Presentation
  2. Hospital Course
  3. Challenges or controversies surrounding management

If selected, participants will have 10-15 minutes to present the case, leaving 15-20 minutes of discussion by the panel and the audience.

This is a great opportunity for fellows and junior faculty to gain experience speaking at a national conference.

Submission Deadline: Thursday, December 15, 2022

Submit A Case


Write to: events@acmt.net

MedTox Shark Tank Research Forum

Two $1500 Travel Scholarships to be awarded as part of the Shark Tank Competition!

The MedTox Shark Tank Research Forum is an opportunity for Fellows-in-Training, Residents, and Medical Students to obtain expert input during the formative stage of a research project. The session objective is to offer valuable insight that could strengthen their proposed research project.

How to Apply

We invite applicants to submit an abstract of a research proposal to this forum. The proposal could represent a planned research project (prior to IRB submission), a proposal awaiting IRB approval, or something that is further along, perhaps into a pilot data collection phase.

To be eligible, you must be a Fellow-in-Training, Resident or Medical Student. The abstract should include:

  1. Title of Presentation
  2. Aims
  3. Significance and Innovation
  4. Research Approach (Methods) and Timeline
  5. Major Limitations/Questions

Submission Deadline: Thursday, December 15, 2022

Submit A Proposal


If you have any questions, please contact ACMT at events@acmt.net.

Open Mic Competition

The ACMT Open Mic Competition offers medical toxicology fellows-in-training, residents, and medical students the opportunity to give a lecture in a national forum where experienced speakers can offer insight on both content and delivery. This session has been shown to be a valuable ACMT professional development feature.

How to Apply

ACMT invites all fellows, residents, and medical students to submit an abstract of a presentation for the Open Mic Competition. Any topic relevant to medical toxicology is appropriate—historical topics, mystery cases, molecular mechanisms, educational development, etc. Above all, we are looking for engaging speakers and interesting presentations. Presenters are chosen by a panel of evaluators. Proposals are evaluated on content and originality.

A complete proposal application includes:

  • Abstract (250 words describing your topic)
  • Objective 1
  • Objective 2
  • Objective 3

Submission Deadline: Thursday, December 15, 2022

Submit A Proposal

How It Works

After initial review of all submissions, a select number of abstracts will be selected for presentation at the 2023 ACMT Annual Scientific Meeting on March 31 - April 2, 2023 in San Diego, CA.

This meeting will be fully in-person. Presenters will be expected to register for the meeting and present in-person on the main stage in San Diego. There will be no virtual option.

During the Open Mic session, selected presenters are required to give their presentation in an Ignite style. This format creates intense and fast presentations with sharp, concise messages. Each presentation must be 5 minutes long and have the following format:

  • 20 slides
  • 15 seconds per slide
  • Slides automatically advance after 15 seconds

This is an example of an Ignite® talk: http://www.youtube.com/watch?v=yGENcskRGRk&feature=youtu.be

More information on the Ignite format can be found here

For more examples of skilled, intellectually stimulating talks, we refer speakers to the TED series of lectures.


If you have any questions, please contact ACMT at events@acmt.net.


Live In-Person Event
03/31/2023 at 8:00 AM (PDT)   |  2 days, 5 hours, 30 minutes  |  Attendance Required
03/31/2023 at 8:00 AM (PDT)   |  2 days, 5 hours, 30 minutes  |  Attendance Required